Repligen
Update in progressRGEN (NasdaqGS)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryMedical Instruments & Supplies
Repligen is a life sciences company that develops and markets bioprocessing technologies and systems worldwide. Its portfolio includes hollow fiber consumables, chromatography and resins, PATsmart real‑time monitoring and control tools, at‑line and high‑resolution analytics, and related filtration and separation systems. It also offers OPUS columns, ELISA kits, and collaborative ligand development with Navigo Proteins. Based in Waltham, MA.
Company score
- Sentiment
- 0.48
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.00
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.00
- Governance
- 0.16
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 0.03
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.26
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Company
- MarketNasdaqGS (NMS)
- LocationUnited States
- CEOMr. Olivier Loeillot
- Founded1981
- Employees2,000
- Websitewww.repligen.com
Identifiers
- ISINUS7599161095
- FIGIBBG000BS48J3
- LEI54930006QJ0T5AUO1E71
- CUSIP759916109
- CIK0000730272